International Conference on Microbial Drug Discovery and Therapeutics

ICMDDT

20th Feb – 21st Feb 2027 Athens, Greece

Official Invitation Letter Available

An official invitation letter will be provided upon successful registration for your participation in the conference.

Benefits of Registering as Listener

Access to All Conference Sessions

Plenary, keynote and parallel sessions

Networking Opportunities

Connect with global educators & researchers

Certificate of Participation

Digital certificate of participation

Invitation Letter Support

Official invitation letter after successful registration

Conference Kit / Digital Materials

E-proceedings & resource materials

Access to Keynote Sessions

Learn from leading experts & scholars

Credit Card

Debit Card

Net Banking

Cash Card

Unified Payments

Select Registration Mode

Standard / Physical Participation USD

Join us on-site for keynotes, talks, workshops, networking, conference kit and certificate.

Virtual Participation USD

Participate online via live streaming. Includes live access to all sessions, digital materials and certificate.

Participant Details

Full Name *

Email Address *

Mobile Number with Country Code *

City *

State *

Country *

Zip / Postal Code *

Address *

Coupon Code

Terms & Condition

I agree to the Terms & Conditions and Refund & Cancellation Policy.

Read the full Terms & Conditions

Registration Summary

Conference ICMDDT

Date 20th Feb – 21st Feb 2027

Location Athens, Greece

Participation Type Listener

Organizer Science Leagues

Registration Mode Standard / Physical

Registration Fee USD 0.00

Bank Convenience Charges (5.8%)i USD 0.00

Calculated based on 5.8% of the registration fee

Discount USD 0.00

Total Payable USD 0.00

100% Secure Payment

Your payment information is encrypted and processed securely.

Conference Session Tracks

Aligned with UN Sustainable Development Goals

The conference's session tracks effectively support the following SDGs.

01 Innovations in Antimicrobial Drug Discovery +

This track focuses on the latest advancements in the discovery of antimicrobial agents. It will explore novel compounds, mechanisms of action, and the potential for overcoming resistance.

SDG 3 SDG 4

02 Molecular Diagnostics in Microbial Pathogenesis +

This session will delve into cutting-edge molecular diagnostic techniques for identifying microbial pathogens. Emphasis will be placed on their application in clinical settings and their role in improving patient outcomes.

SDG 3 SDG 4

03 Translational Research in Microbial Therapeutics +

This track aims to bridge the gap between laboratory research and clinical application of microbial therapeutics. Discussions will include successful case studies and challenges faced in translational research.

SDG 3 SDG 9

04 Clinical Research on Antimicrobial Resistance +

This session will address the growing challenge of antimicrobial resistance in clinical settings. Researchers will present findings on resistance mechanisms and strategies for effective management.

SDG 3 SDG 4

05 Laboratory Techniques in Microbial Drug Development +

This track will highlight innovative laboratory techniques used in the development of microbial drugs. Participants will discuss methodologies that enhance the efficiency and effectiveness of drug discovery.

SDG 3 SDG 9

06 Pathogen-Host Interactions: Implications for Therapy +

This session will explore the complex interactions between pathogens and their hosts. Understanding these dynamics is crucial for developing targeted therapeutic strategies.

SDG 3 SDG 4

07 Therapeutic Innovations in Microbial Infections +

This track will showcase novel therapeutic approaches for treating microbial infections. Emphasis will be placed on innovative strategies that address current limitations in treatment.

SDG 3 SDG 4

08 Biotechnology Applications in Microbial Drug Discovery +

This session will focus on the role of biotechnology in enhancing microbial drug discovery processes. Participants will discuss biotechnological advancements that facilitate the identification and development of new therapeutics.

SDG 3 SDG 9

09 Emerging Trends in Microbial Therapeutics +

This track will examine emerging trends and future directions in microbial therapeutics. Discussions will include the impact of new technologies and research findings on therapeutic development.

SDG 3 SDG 9

10 Regulatory Challenges in Microbial Drug Development +

This session will address the regulatory landscape surrounding microbial drug development. Experts will discuss the challenges and opportunities in navigating regulatory pathways for new therapeutics.

SDG 3 SDG 4

11 Global Perspectives on Microbial Drug Resistance +

This track will provide a global overview of microbial drug resistance and its implications for public health. Participants will share insights on international efforts to combat resistance and promote effective therapies.

SDG 3 SDG 4